Atome secured final investment decision for a $665 million low-carbon calcium ammonium nitrate plant in Paraguay, partnering with Yara for 260,000 tonnes annual supply starting in 2029.
Elementis reported increased operating profits driven by cost-cutting and the $40M sale of its pharma business to ABF, projecting 2026 as a year of progress.
Elementis has acquired Alchemy Ingredients, a UK developer of sustainable rheology modifiers for personal care, to expand its product portfolio.
Elementis anticipates full-year earnings will meet estimates, citing stable Q3 revenue and improved operating profit, alongside a goal of $12 million in cost savings by year-end.
ChemBrief